Sven Liebig

7PUBLICATIONS
60CO-AUTHORS
Gene and molecular therapyEpidemiological methodsMajor global burdens of diseaseHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Apr 12, 2025
Pneumocystis Jirovecii Pneumonia: The Potential of KEX1, MSG1, and MSG2 as Key Antigens in Cytokine Release Assays.

F A Ottilie Neumann, Markus Müller, Gregor Mattert

|Jun 08, 2024
Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemia.

Liliana H Mochmann, Denise Treue, Michael Bockmayr

|Feb 20, 2024
Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity.

Francis Baumgartner, Stefanos A Bamopoulos, Laura Faletti

|Aug 02, 2022
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma.

Guus J J E Heynen, Francis Baumgartner, Michael Heider

Pageof 2